Status:
RECRUITING
Evaluation of Ablation Lesions Using Cardiovascular Magnetic Resonance Imaging
Lead Sponsor:
R&D Cardiologie
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Ineffective ablation lesions can cause arrhythmia recurrence after catheter ablation for cardiac arrhythmia. Ablation lesions can be created with various ablation energy modalities. This study uses ca...
Detailed Description
Catheter ablation has become a cornerstone in the treatment of atrial fibrillation (AF). Typically, radiofrequency ablation (RFA) and cryoballoon ablation are used to perform pulmonary vein isolation ...
Eligibility Criteria
Inclusion
- Adult patients (age ≥18 years old)
- Paroxysmal or persistent atrial fibrillation, meeting criteria of the 2020 European Society of Cardiology Guidelines for diagnosis and management of atrial fibrillation
- Patients scheduled to undergo catheter ablation for cardiac arrhythmia using one of the following techniques: Radiofrequency ablation (High power, short duration), Ultra-low temperature cryo ablation, or Pulsed field ablation
Exclusion
- Known (or suspected) allergic reaction to gadolinium
- Contraindications for MRI (such as claustrophobia, certain implants, devices, high body mass index).
- Pregnancy or breastfeeding
- Prior intervention in the left atrium (ablation or surgery)
Key Trial Info
Start Date :
March 8 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2028
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05432024
Start Date
March 8 2023
End Date
April 1 2028
Last Update
July 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Antonius Hospital
Nieuwegein, Netherlands, 3435 CM